Equities researchers at Maxim Group initiated coverage on shares of Medicus Pharma (NASDAQ:MDCX – Get Free Report) in a research note issued to investors on Tuesday,Benzinga reports. The firm set a “buy” rating and a $10.00 price target on the stock. Maxim Group’s price target indicates a potential upside of 238.98% from the company’s previous close.
Medicus Pharma Trading Up 7.3 %
Shares of NASDAQ:MDCX opened at $2.95 on Tuesday. Medicus Pharma has a 52-week low of $1.80 and a 52-week high of $6.00.
Medicus Pharma Company Profile
Read More
- Five stocks we like better than Medicus Pharma
- What Are Treasury Bonds?
- 3 Dividend Leaders Set for Strong Growth in 2025
- Best Stocks Under $5.00
- 3 Stocks to Gain From Stockpiling Effects of the Trump Tariffs
- The Most Important Warren Buffett Stock for Investors: His Own
- These 3 Stocks Look to Power AI Data Centers With Natural Gas
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
